There is limited data for counseling and management of periviable small for gestational age fetuses. We aim to investigate short term outcome in periviable SGA fetuses and relate this to the underlying cause.
INTRODUCTION
Despite recent improvements in perinatal survival after birth at preterm gestation as detailed in large prospective studies such as TRUFFLE 1 , EPICURE 2 , or GRIT 3 , management of pregnancies with a very small fetus near the limit of viability remains a challenge 4 . The perinatal and 2-year neurodevelopmental outcomes of growth restricted babies identified after 26 weeks have been evaluated and well characterised in randomised controlled trials, aiding prognostication and counselling 1, 3, 5 . However, when the diagnosis occurs before 26 weeks of gestation, there are scant data to aid in counseling regarding prognosis; this is particularly important as babies with these conditions combine two major risk factors for morbidity and mortality: pathological smallness and likely extreme prematurity 6, 7 . This is usually due to medically indicated preterm delivery because of fetal deterioration or maternal complications.
Careful counseling of the parents is required in such cases in order to have realistic expectations of
what the outcome is likely to be, in order to reach a decision on whether (and, if so, when) intervention by delivery is appropriate or desirable 3, 6 and what level of neonatal intervention is likely to be required. Given the very limited data on which these decisions are based currently, we aimed to determine the outcome of periviable SGA babies in relation to the likely underlying cause and its natural history in fetuses that were structurally and presumed to be chromosomally/genetically normal at the time of SGA diagnosis.
It is important to note that the terms small for gestational age (SGA) and fetal growth restriction (FGR) are frequently used in different ways and the definitions are not uniform even in international guidelines. We therefore use the term SGA to describe a fetus whose size based on ultrasound scan is very small in relation to gestation without any other qualifying characteristics.
MATERIALS AND METHODS
This was a multicentre retrospective database study conducted in the fetal medicine departments were routinely and retrospectively collected and datasets were fully anonymised prior to analysis.
Once the cases were identified, review of electronic ultrasound records and, where appropriate, case notes was undertaken.
The first qualifying ultrasound scan within the set gestation was considered to be the "sentinel scan" and its findings were analysed for the study. Fetuses where intrauterine death (IUD) was diagnosed at the sentinel scan were not included in this study. The cases were classified into one of four mutually exclusive categories depending on suspected underlying cause:
-Uteroplacental: uterine artery PI above 95th percentile for gestation and/or bilateral notches and/or reduced amniotic fluid.
-Placental: ultrasound evidence of placental abnormality (thickened placenta, extensive lakes or jelly like appearance) with the presence of normal uterine artery Doppler assessment (PI below the 95 th centile and absence of bilateral notches).
-Congenital infection.
-Unclassified: in cases that did not fulfill the criteria for the defined categories above, and where no antenatal cause of fetal growth restriction was initially identified.
Statistical data analysis was performed with SPSS Statistical software version 20. Outcome frequencies were calculated and compared across the groups with the Kruskal-Wallis test. We considered p<0.05 as significant.
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RESULTS
471 pregnancies were identified: 239 from QCCH, 51 from GSTH and 181 from SGH. 245/471 singleton pregnancies fulfilled the inclusion criteria ( Figure 1 There were no significant differences between the baseline demographic data (maternal age, gestation at diagnosis, AC, EFW, placental appearance) for the cases analysed (245 cases of structurally normal fetuses with known outcome) and those cases of structurally normal fetuses excluded because of missing outcome data (79 cases). However, PE was more common in those analysed compared to those with no outcome (33% versus 16% p=0.04). Of 245 pregnancies, 33 underwent termination of pregnancy by fetocide or medical TOP; 89 died in utero (IUD) and 123
were liveborn. Of these 101/123 (82%) survived the neonatal period. Figure 2 shows the fetal outcome by categorisation at sentinel scan. Of the 123 babies born alive those born below 28 weeks the survival rate was 13%. Survival increased progressively to 59% between 28 and 32 weeks, to 80% between 32 and 36 weeks and to 94% above 36 weeks (Table 1 and The relationship between antenatal and delivery characteristics in relation to postnatal outcome are shown in table 4 : those babies that survived had higher birthweights and a longer diagnosisdelivery interval then those that were IUD, NND and underwent TOP. There were significant differences in the median birthweight, diagnosis-to-delivery interval and Table 5 shows the outcomes by categorisation of SGA: the incidence of PE was highest in SGA associated with uteroplacental insufficiency (34%) and gestation longest in those cases that were unclassified (34.9 weeks). APGAR scores between those fetuses that survived and those that suffered a neonatal death (NND).
There were 143/245 (58.5%) vaginal deliveries and among these two were instrumental deliveries.
In 2/245 (1%) no information on mode of delivery was available. Of the 99/245 (40.5%) Caesarean sections, 64/99 (65%) were planned Caesarean sections and 35 (35%) were emergency procedures.
Among the 101/245 fetuses (41%) that survived, 82/101 (81%) were delivered by Caesarean section and 18/101 (18%) were delivered vaginally. In one survivor, the mode of delivery was unknown.
There were 22/245 neonatal deaths. 5/22 (23%) were delivered vaginally and 16/22 (72.5%) were delivered by Caesarean section. In one neonatal death the mode of delivery was unknown.
DISCUSSION
In this cohort of very small fetuses identified at periviable gestation, survival overall was 41% and, ranging from 13% if delivery was <28 weeks up to >90% if babies were delivered at beyond 36
weeks. The majority of these cases had uteroplacental insufficiency. Noteworthy is that where severely small fetal biometry was identified at periviable gestation, 15% of pregnancies were delivered after 36 weeks with good outcome. Outcome is worse in cases of uteroplacental insufficiency than in those with a primary placental cause; nearly one third of women with uteroplacental SGA develop PET, twice as many as those with placental cause or unclassified SGA.
The pregnancies progressing longest from diagnosis and with the best prognosis are those where a cause for SGA cannot be classified at the sentinel scan. These data are of clinical relevance as counseling for parents can be based on the cause identified at sentinel scan.
The small fetus remains a challenge to define and diagnose and there may be overlap between SGA and true FGR, especially if diagnosed at periviable gestation 10 . Doppler and placental assessment carries both diagnostic and prognostic value 11 allowing most fetuses to be classified at presentation. The great majority of structurally normal fetuses found to measure very small at periviable gestation were classified into the utero-placental category, a smaller number of pregnancies being affected by primary placental abnormality and only one by a confirmed viral infection. Twelve percent had no obvious antenatal pathological cause found at sentinel scan and the majority of these fetuses (53%) survived, with the others dying as a result of TOP, IUD or NND.
Although it was not possible at time of diagnosis to differentiate between FGR and SGA in all cases, the unclassified cases were likely to represent SGA as they showed no stigmata of uteroplacental or placental problems and some reached a gestation close to term.
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In very small fetuses at periviable gestation the differentiation between SGA and FGR is important as it guides prognosis. By measuring and describing the relevant ultrasound findings we are able to classify most fetuses at presentation at periviable gestation, however it remains difficult to predict with any level of precision which fetuses will die in utero or which will progress for many weeks or even to term before requiring delivery. Though termination of pregnancy is often discussed at initial presentation, given the range in gestation at eventual delivery may be far greater than expected, there is in fact little to be lost by conservative management.
When the small fetus has reached a potentially viable weight and gestation the challenge is to optimise timing of delivery: balancing the risk between intrauterine demise or hypoxic damage while gaining maturity versus delivering a live baby at risk of neonatal complications from prematurity and underlying growth restriction
. Post delivery neonatal morbidity in fetuses with
severe FGR includes respiratory and gastro-intestinal complications and neuro-developmental delay. Not surprisingly, the prognosis of a structurally normal, growth restricted fetus is determined by gestation at delivery, birthweight and cardiovascular status 12, 13, 14, 15 .
The strength of this study is that we collected data from three large specialist perinatal centres, making it the largest dataset on periviable fetal growth restriction reported. The three centres had similar reporting and management strategies, though they cannot be considered to be entirely uniform as no guidelines existed (or indeed even exist now) in relation to periviable SGA. This latter point emphasizes the importance of our data and findings. The cases are well characterised and almost all the antenatal and outcome data were held in computerised databases. The data are likely to be valid in other populations due to the diverse mix of ethnicities and socioeconomic backgrounds. We acknowledge the limitations of these data which was retrospectively collected and necessarily only cases where the outcome was known could be included.
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Further, it was not possible to investigate the effect of steroid administration, magnesium sulphate use and mode of delivery as this information was not held in the fetal medicine databases and not uniformly documented in delivery databases. This does not affect the validity of the findings, but it does mean that the perinatal/obstetric factors that may contribute to better or worse outcome could not be sub-analyzed. There were a number of cases lost to follow up but this was not a systematic failing as the demographic details did not differ between the cases where outcome was known and not known. No longer term infant or child follow up data are included:
this is desirable for a future prospective study.
CONCLUSION
This study contributes to the knowledge on short term outcome of severely small fetuses diagnosed at the limits of viability. The findings suggest that many pregnancies progress weeks beyond what might be envisaged and several unexpectedly reached close to term. We urge caution in offering termination of pregnancy as it is frequently impossible to prognosticate and in particular to predict how long the pregnancy will progress. Outcome based on categorisation of small-for-gestational-age Flow chart (according to STROBE guidelines) for inclusion of cases
Total included cases n= 471
Viable singleton pregnancies at 22+0 rd Excluded because of abnormality at sentinel scan: n=147 1) Genetic / chromosomal anomaly n=47
No abnormality but excluded as no outcome available postnatally:
Included in analysis:
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